BioSpace News Archive

Magenta Therapeutics (NASDAQ:MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients, today announced it will host a conference call on Thursday, May 7, 2020 at 8:00am ET to discuss recent business updates. The call will also feature a discussion of current stem cell transplant practices by a transplant key opinion leader. To access

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2020 second quarter ended March 31, 2020, following the close of market on Thursday, May 7, 2020. The company plans to hold a conference call and live audio webcast for analys

Replimune Group Inc. announced it will host a conference call to provide updated data from patients with melanoma and non-melanoma skin cancers treated with RP1 combined with Opdivo® in its ongoing Phase 1/2 clinical trial.

AcelRx Pharmaceuticals, Inc. announced that DSUVIA achieved Milestone C approval, a decision that clears the path for DSUVIA to be included in military sets, kits and outfits.

Quarterly net revenues of $101.8 million, representing 39 percent growth versus the first quarter 2019 and 3 percent growth versus the fourth quarter 2019

First Quarter 2020 Revenues of $630.6 million, up 2.8% Versus Prior Year Period; up 4.0% on a Constant Currency Basis

Bio-Techne Corporation reported its financial results for the third quarter ended March 31, 2020.

BIOLASE, Inc., the global leader in dental lasers, announced that it will release first quarter 2020 financial and operating results on Thursday, May 7, 2020 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments..

Live Chat to Discuss Current Clinical and Translational Response to the Novel Coronavirus

Torben Jørgensen, Chairman of the Board in Biotage AB, informed the company that he has sold part of his shareholding in Biotage on 29 April 2020.